Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer-Reference-Cited by-同舟云学术

Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer

Published:2020-11-27 Issue:1 Volume:56 Page:81-85
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Aronen Anu¹^ORCID,Aittoniemi Janne²,Huttunen Reetta³,Nikkola Anssi¹⁴,Rinta-Kiikka Irina⁴⁵,Nikkola Jussi¹,Limnell Olli⁴,Nordback Isto¹,Sand Juhani¹,Laukkarinen Johanna¹⁴

Affiliation:

1. Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland;

2. Fimlab Laboratories, Tampere, Finland;

3. Department of Internal Medicine, Tampere University Hospital, Tampere, Finland;

4. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;

5. Department of Radiology, Tampere University Hospital, Tampere, Finland

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2020.1849383

Reference32 articles.

1. Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

2. Preoperative Plasma Soluble Urokinase Plasminogen Activator Receptor as a Prognostic Marker in Rectal Cancer Patients. An Eortc-Receptor and Biomarker Group Collaboration

3. Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer

4. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

5. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD87-targeted BiTE and CAR-T cells potently inhibit invasive nonfunctional pituitary adenomas;Science China Life Sciences;2024-07-08

2. Prognostic role of suPAR in acute pancreatitis: A protocol for systematic review;Medicine;2024-06-28

3. Diagnostic Differentiation between Pancreatitis and Pancreatic Cancer: A Scoping Review;Diagnostics;2024-01-29

4. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer;Cancers;2023-11-25

5. Plasma soluble urokinase-type plasminogen activator receptor (P-suPAR) in the diagnostics between malignant and non-malignant pancreatic lesions;Pancreatology;2023-03